Haerim Chung

527 total citations
46 papers, 352 citations indexed

About

Haerim Chung is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Haerim Chung has authored 46 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 13 papers in Molecular Biology and 11 papers in Immunology. Recurrent topics in Haerim Chung's work include Acute Myeloid Leukemia Research (13 papers), Immune Cell Function and Interaction (9 papers) and Lymphoma Diagnosis and Treatment (9 papers). Haerim Chung is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Immune Cell Function and Interaction (9 papers) and Lymphoma Diagnosis and Treatment (9 papers). Haerim Chung collaborates with scholars based in South Korea, Switzerland and Germany. Haerim Chung's co-authors include June‐Won Cheong, Jin Seok Kim, Ji Eun Jang, Yoo Hong Min, Hyunsoo Cho, Soo‐Jeong Kim, Yu Ri Kim, Yundeok Kim, Jung Yeon Lee and Hyunsung Park and has published in prestigious journals such as Journal of Clinical Oncology, Blood and ACS Nano.

In The Last Decade

Haerim Chung

43 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haerim Chung South Korea 12 123 122 93 81 73 46 352
Miki Kiyota Japan 10 137 1.1× 104 0.9× 93 1.0× 107 1.3× 101 1.4× 23 319
Iris Amitay‐Laish Israel 10 50 0.4× 81 0.7× 101 1.1× 93 1.1× 91 1.2× 25 348
Julie C. Porcher United States 8 106 0.9× 65 0.5× 126 1.4× 213 2.6× 69 0.9× 13 399
Yoshitomo Maesako Japan 10 105 0.9× 91 0.7× 115 1.2× 173 2.1× 97 1.3× 21 370
Minami Yamada Japan 12 77 0.6× 154 1.3× 134 1.4× 90 1.1× 104 1.4× 24 369
Luk Cox Belgium 9 195 1.6× 115 0.9× 99 1.1× 86 1.1× 59 0.8× 12 432
Massimo Pini Italy 10 80 0.7× 112 0.9× 136 1.5× 128 1.6× 115 1.6× 26 382
Jinjun Cheng United States 10 171 1.4× 155 1.3× 61 0.7× 54 0.7× 26 0.4× 24 377
Katharina Lisenko Germany 13 104 0.8× 128 1.0× 77 0.8× 48 0.6× 41 0.6× 24 309
Massimiliano De Bortoli Italy 10 183 1.5× 78 0.6× 144 1.5× 25 0.3× 94 1.3× 20 412

Countries citing papers authored by Haerim Chung

Since Specialization
Citations

This map shows the geographic impact of Haerim Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haerim Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haerim Chung more than expected).

Fields of papers citing papers by Haerim Chung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haerim Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haerim Chung. The network helps show where Haerim Chung may publish in the future.

Co-authorship network of co-authors of Haerim Chung

This figure shows the co-authorship network connecting the top 25 collaborators of Haerim Chung. A scholar is included among the top collaborators of Haerim Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haerim Chung. Haerim Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kim, Sojeong, Jeong-Eun Kwak, June‐Young Koh, et al.. (2025). NKG2D-mediated cytotoxicity of CD4 cytotoxic T cells in multiple myeloma. Blood. 146(4). 456–470. 3 indexed citations
3.
Cho, Hyunsoo, Ji Eun Jang, Seung‐Tae Lee, et al.. (2024). NUP98 is rearranged in 5.0% of adult East Asian patients with AML. Blood Advances. 8(19). 5122–5125. 3 indexed citations
4.
Kim, Sojeong, Haerim Chung, Jeong-Eun Kwak, et al.. (2024). Clearing soluble MIC reverses the impaired function of natural killer cells from patients with multiple myeloma. Journal for ImmunoTherapy of Cancer. 12(1). e007886–e007886. 5 indexed citations
6.
Yeom, Joon‐Sup, Jun Yong Choi, Nam Su Ku, et al.. (2024). Long-Term Outcomes of COVID-19 and Risk Factors for Prolonged or Persistent COVID-19 in Lymphoma Patients: A Multicenter, Retrospective Cohort Study. Journal of Korean Medical Science. 39(41). e263–e263. 1 indexed citations
7.
Cho, Hyunsoo, Kyung Hwan Kim, Hoyoung Lee, et al.. (2021). Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple Myeloma. Clinical Cancer Research. 27(10). 2947–2958. 31 indexed citations
8.
Jeon, Ho Jong, et al.. (2021). Evaluation of Spontaneous and Radiation-Induced Micronucleus Frequency in Cultured Human Peripheral Blood Lymphocytes Depending on Age and Sex. Journal of Radiation Protection and Research. 27(4). 239–247. 1 indexed citations
9.
Kim, Yu Ri, Soo‐Jeong Kim, Hye Sun Lee, et al.. (2021). Predictive Factors of Event-Free Survival at 24 Months in Patients with Peripheral T-Cell Lymphoma: A Retrospective Study. Cancer Research and Treatment. 54(2). 613–620. 3 indexed citations
10.
Shin, Saeam, Hyunsoo Cho, Haerim Chung, et al.. (2021). Ig Gene Clonality Analysis Using Next-Generation Sequencing for Improved Minimal Residual Disease Detection with Significant Prognostic Value in Multiple Myeloma Patients. Journal of Molecular Diagnostics. 24(1). 48–56. 12 indexed citations
11.
Cho, Hyunsoo, Ji Eun Jang, Haerim Chung, et al.. (2021). Arsenic trioxide synergistically promotes the antileukaemic activity of venetoclax by downregulating Mcl-1 in acute myeloid leukaemia cells. Experimental Hematology and Oncology. 10(1). 28–28. 16 indexed citations
12.
Hyun, Shin Young, Ji Eun Jang, Haerim Chung, et al.. (2020). Immunosuppressive role of CD11b+CD33+HLA‐DR myeloid‐derived suppressor cells‐like blast subpopulation in acute myeloid leukemia. Cancer Medicine. 9(19). 7007–7017. 23 indexed citations
13.
Chung, Haerim, Ji Eun Jang, Soo‐Jeong Kim, et al.. (2020). Serum albumin and C-reactive protein as significant predictors of non-relapse mortality in lower gastrointestinal graft-versus-host disease. Annals of Hematology. 99(5). 1111–1119. 4 indexed citations
14.
Jang, Ji Eun, et al.. (2020). ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia. Journal of Experimental & Clinical Cancer Research. 39(1). 85–85. 30 indexed citations
15.
Jang, Ji Eun, Haerim Chung, Soo‐Jeong Kim, et al.. (2019). Early Cytomegalovirus Reactivation and Expansion of CD56brightCD16dim/−DNAM1+ Natural Killer Cells Are Associated with Antileukemia Effect after Haploidentical Stem Cell Transplantation in Acute Leukemia. Biology of Blood and Marrow Transplantation. 25(10). 2070–2078. 14 indexed citations
16.
Hyun, Shin Young, Ji Eun Jang, Haerim Chung, et al.. (2019). Induction of apoptosis and differentiation by Na/H exchanger 1 modulation in acute myeloid leukemia cells. Biochemical and Biophysical Research Communications. 519(4). 887–893. 7 indexed citations
17.
Kim, Yu Ri, Soo‐Jeong Kim, June‐Won Cheong, et al.. (2017). Pretreatment Epstein-Barr virus DNA in whole blood is a prognostic marker in peripheral T-cell lymphoma. Oncotarget. 8(54). 92312–92323. 12 indexed citations
18.
Cho, Hyunsoo, Soo‐Jeong Kim, Chi Young Shim, et al.. (2017). Prognostic significance of interventricular septal thickness in patients with AL amyloidosis. Leukemia Research. 60. 36–43. 4 indexed citations
19.
Cho, Hyunsoo, Jong Hee Chang, Yu Ri Kim, et al.. (2016). The role of upfront autologous stem cell transplantation in high‐risk younger patients with primary central nervous system lymphoma. British Journal of Haematology. 174(3). 444–453. 11 indexed citations
20.
Jang, Ji Eun, Yu Ri Kim, Soo‐Jeong Kim, et al.. (2016). A new prognostic model using absolute lymphocyte count in patients with primary central nervous system lymphoma. European Journal of Cancer. 57. 127–135. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026